HIV/AIDS Treatment and Care : Clinical protocols for the European ...

More documents

Recommendations

Info

Contents I. Prevention strategies............................................................................................................. 303 1. Vaccination against hepatitis B and A................................................................................. 303 1.1. Hepatitis B ................................................................................................................... 303 1.2. Hepatitis A.................................................................................................................... 304 2. Prevention of mother-to-child transmission........................................................................ 305 2.1. PMTCT of HBV .......................................................................................................... 305 2.2. PMTCT of HCV .......................................................................................................... 306 3. Preventing and reducing risk of infection........................................................................... 306 3.1. Safer sexual behaviour................................................................................................. 306 3.2. Reducing harm related to injecting drug use ............................................................... 306 4. Counselling to reduce liver-related harm............................................................................ 306 5. Prevention of transmission through transfusion of blood and blood products ................... 307 6. Prevention in health care settings........................................................................................ 307 References.................................................................................................................................... 308
Page 1 and 2:
HIV/AIDS TREATMENT AND CARE Clinica
Page 3 and 4:
© World Health Organization 2007 A
Page 5 and 6:
iv Acknowledgements The editors wou
Page 7 and 8:
vi Marco Vitoria (WHO headquarters)
Page 9 and 10:
viii CRP C-reactive protein CS caes
Page 11 and 12:
x LFT liver function test LGE linea
Page 13 and 14:
xii TDM therapeutic drug monitoring
Page 15 and 16:
xiv Introduction HIV is a chronic i
Page 18 and 19:
��
Page 20 and 21:
Annex 7. Glossary .................
Page 22 and 23:
HIV/AIDS TREATMENT AND CARE CLINICA
Page 24 and 25:
HIV/AIDS TREATMENT AND CARE CLINICA
Page 26 and 27:
10 HIV/AIDS TREATMENT AND CARE CLIN
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
1 HIV/AIDS TREATMENT AND CARE CLINI
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 65 and 66:
��
Page 68 and 69:
I. Principles management of opportu
Page 70 and 71:
management of opportunistic infecti
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Table 8. pcp second-line treatment
Page 78 and 79:
Page 80 and 81:
Table 12. oesophageal and dissemina
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
5.9.1.2. Treatment Table 15. treatm
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
��
Page 103 and 104:
palliative care for people living w
Page 105 and 106:
Page 107 and 108:
III. Initial evaluation palliative
Page 109 and 110:
IV. Treatment palliative care for p
Page 111 and 112:
Fig. 2. who analgesic ladder for ma
Page 113 and 114:
Type of pain or treatment Usual sta
Page 115 and 116:
Page 117 and 118:
Table 5. prevalence of symptoms in
Page 119 and 120:
Type Symptoms Possible causes Disea
Page 121 and 122:
Type Symptoms Possible causes Disea
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Table 22. Management of mania and B
Page 135 and 136:
Table 24. Management of cough or di
Page 137 and 138:
V. Special advice for terminal care
Page 139 and 140:
Table 27. common manifestations in
Page 141 and 142:
Page 143 and 144:
References palliative care for peop
Page 145 and 146:
��
Page 147 and 148:
VI. Suggested minimum data to be co
Page 149 and 150:
136 HIV/AIDS TREATMENT AND CARE CLI
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Contents I. Policy and principles .
Page 175 and 176:
I. Policy and principles HIV/AIDS T
Page 177 and 178:
HIV/AIDS TREATMENT AND CARE FOR INJ
Page 179 and 180:
° bacterial pneumonia ° endocardi
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Social factors are: • homelessnes
Page 199 and 200:
Table 3. Interactions between ARV d
Page 201 and 202:
Page 203 and 204:
Other medications Use Rifampicin (R
Page 205 and 206:
Table 5. Interactions of illicit dr
Page 207 and 208:
Page 209 and 210:
ANNEX 1 ASI6 C © 2004 University o
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
• Cardiovascular Hypertension Tac
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235:
Page 238 and 239:
Contents I. Epidemiology and natura
Page 240 and 241:
ManageMent of Hepatitis C and HiV C
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261: ManageMent of Hepatitis C and HiV C
Page 272 and 273: Annex 3. Alcohol screening question
Page 278 and 279: Table 16. a sample of the drug pipe
Page 284 and 285: ��
Page 286 and 287: 3.2. Considerations regarding treat
Page 288 and 289: 278 hiv/aids tReatment and caRe cLi
Page 309: ��
Page 313 and 314: 304 HIV/AIDS TREATMENT AND CARE CLI
Page 319 and 320: Contents I. Introduction ..........
Page 321 and 322: I. Introduction support for sexual
Page 323 and 324: III. Principles of SRH Services for
Page 325 and 326: IV. Sexual health of PLHIV support
Page 327 and 328: support for sexual and reproductive
Page 333 and 334: STI/RTI agent STI/RTI agent dosage
Page 335 and 336: V. Contraception support for sexual
Page 357 and 358: 4. Are you on any medicine to help
Page 361 and 362:
support for sexual and reproductive
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 370:
Contents I. Policy issues .........
Page 373 and 374:
Page 375 and 376:
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Contents I. Introduction ..........
Page 399 and 400:
I. Introduction Paediatric HiV/aidS
Page 401 and 402:
Fig 1. HiV virological diagnosis in
Page 403 and 404:
Paediatric HiV/aidS treatment and c
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Clinical manifestations Laboratory
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
6. Fungal infections 6.1. Candidias
Page 423 and 424:
7. Viral infections 7.1. Cytomegalo
Page 425 and 426:
7.2.3. Treatment Table 18. treatmen
Page 427 and 428:
V. Paediatric HIV pain management P
Page 430 and 431:
Page 432:
Page 435 and 436:
� � ��
Page 437 and 438:
References Paediatric HiV/aidS trea
Page 439 and 440:
Page 441:
Page 444 and 445:
Contents I. Introduction ..........
Page 446 and 447:
I. Introduction ImmunIzatIon of Peo
Page 448 and 449:
ImmunIzatIon of PeoPle lIvIng wIth
Page 450 and 451:
Page 452 and 453:
Page 454 and 455:
Page 456 and 457:
Page 458 and 459:
Page 460 and 461:
Page 462 and 463:
Page 464 and 465:
Annex 3. Rabies vaccines ImmunIzatI
Page 466 and 467:
Page 468 and 469:
References ImmunIzatIon of PeoPle l
Page 470 and 471:
��
Page 472 and 473:
Annex 4. Proposed non-occupational
Page 474 and 475:
Page 476 and 477:
Page 478 and 479:
Page 480 and 481:
Page 482 and 483:
Page 484 and 485:
Page 486 and 487:
Page 488 and 489:
Page 490 and 491:
Page 492 and 493:
Page 494 and 495:
Page 496 and 497:
Page 498 and 499:
Page 500 and 501:
show all

HIV/AIDS Treatment and Care : Clinical protocols for the European ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?